BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 24847444)

  • 1. Murine models of acute leukemia: important tools in current pediatric leukemia research.
    Jacoby E; Chien CD; Fry TJ
    Front Oncol; 2014; 4():95. PubMed ID: 24847444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myelodysplasia and the leukemias.
    Jacobs P
    Dis Mon; 1997 Aug; 43(8):505-97. PubMed ID: 9301644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigational treatment options in phase I and phase II trials for relapsed or refractory acute lymphoblastic leukemia in pediatric patients.
    Asare JM; Rabik CA; Muller B; Brown PA; Cooper S
    Expert Opin Investig Drugs; 2021 Jun; 30(6):611-620. PubMed ID: 33896328
    [No Abstract]   [Full Text] [Related]  

  • 4. Pediatric relapsed or refractory leukemia: new pharmacotherapeutic developments and future directions.
    August KJ; Narendran A; Neville KA
    Drugs; 2013 Apr; 73(5):439-61. PubMed ID: 23568274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
    Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in pediatric acute lymphoblastic and myeloid leukemia.
    Ravindranath Y
    Curr Opin Oncol; 2003 Jan; 15(1):23-35. PubMed ID: 12490758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antileukemic Efficacy of Continuous vs Discontinuous Dexamethasone in Murine Models of Acute Lymphoblastic Leukemia.
    Ramsey LB; Janke LJ; Payton MA; Cai X; Paugh SW; Karol SE; Kamdem Kamdem L; Cheng C; Williams RT; Jeha S; Pui CH; Evans WE; Relling MV
    PLoS One; 2015; 10(8):e0135134. PubMed ID: 26252865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Childhood leukemias--current status and future perspective.
    Pui CH
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1995; 36(5):322-7. PubMed ID: 8607355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of new agents evaluated against pediatric acute lymphoblastic leukemia by the Pediatric Preclinical Testing Program.
    Jones L; Carol H; Evans K; Richmond J; Houghton PJ; Smith MA; Lock RB
    Leukemia; 2016 Nov; 30(11):2133-2141. PubMed ID: 27416986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of the Central Nervous System Microenvironment in Pediatric Acute Lymphoblastic Leukemia.
    Gossai NP; Gordon PM
    Front Pediatr; 2017; 5():90. PubMed ID: 28491865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
    Foffi G; Pastore A; Piazza F; Temussi PA
    Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antileukemia and antitumor effects of the graft-versus-host disease: a new immunovirological approach.
    Sinkovics JG
    Acta Microbiol Immunol Hung; 2010 Dec; 57(4):253-347. PubMed ID: 21183421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent progress in the treatment of acute leukemia].
    Kimura Y
    Gan To Kagaku Ryoho; 2003 Jul; 30(7):895-901. PubMed ID: 12894700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress and Prospects in Pediatric Leukemia.
    Madhusoodhan PP; Carroll WL; Bhatla T
    Curr Probl Pediatr Adolesc Health Care; 2016 Jul; 46(7):229-241. PubMed ID: 27283082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The future of cellular immunotherapy for childhood leukemia.
    Bonifant CL; Tasian SK
    Curr Opin Pediatr; 2020 Feb; 32(1):13-25. PubMed ID: 31851053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of CXCR4-mediated bone marrow colonization in CNS infiltration by T cell acute lymphoblastic leukemia.
    Jost TR; Borga C; Radaelli E; Romagnani A; Perruzza L; Omodho L; Cazzaniga G; Biondi A; Indraccolo S; Thelen M; Te Kronnie G; Grassi F
    J Leukoc Biol; 2016 Jun; 99(6):1077-87. PubMed ID: 26931577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current status of cancer immunotherapy for relapsed/refractory acute lymphoblastic leukemia in children and adolescents in Japan].
    Imai C
    Rinsho Ketsueki; 2020; 61(6):673-681. PubMed ID: 32624542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of the Use of Murine Models in Leukemia and Lymphoma Research.
    Kohnken R; Porcu P; Mishra A
    Front Oncol; 2017; 7():22. PubMed ID: 28265553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adoptive immunotherapy following allogeneic bone marrow transplantation.
    Dazzi F; Goldman JM
    Annu Rev Med; 1998; 49():329-40. PubMed ID: 9509267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.